IRIS
DIGIACOMO, GRAZIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.615
EU - Europa 1.148
AS - Asia 1.034
SA - Sud America 237
AF - Africa 61
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.098
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.597
IT - Italia 506
SG - Singapore 430
CN - Cina 325
BR - Brasile 190
IE - Irlanda 155
SE - Svezia 109
DE - Germania 99
HK - Hong Kong 71
VN - Vietnam 69
NL - Olanda 49
IN - India 40
ZA - Sudafrica 38
RU - Federazione Russa 36
FR - Francia 31
BE - Belgio 29
GB - Regno Unito 25
AR - Argentina 24
FI - Finlandia 22
AT - Austria 19
ID - Indonesia 12
UA - Ucraina 12
CI - Costa d'Avorio 11
KR - Corea 11
PL - Polonia 11
TR - Turchia 11
IQ - Iraq 10
CA - Canada 9
ES - Italia 9
JP - Giappone 9
PK - Pakistan 9
BD - Bangladesh 7
CZ - Repubblica Ceca 7
LT - Lituania 7
EC - Ecuador 6
MX - Messico 6
CO - Colombia 5
RO - Romania 5
UZ - Uzbekistan 5
PY - Paraguay 4
TN - Tunisia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
JO - Giordania 3
LU - Lussemburgo 3
AZ - Azerbaigian 2
CL - Cile 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MA - Marocco 2
MK - Macedonia 2
PS - Palestinian Territory 2
QA - Qatar 2
AD - Andorra 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.098
Salva come PNG Salva come JPEG
Città #
Dallas 262
Ann Arbor 234
Singapore 224
Ashburn 192
Dublin 155
Chandler 148
Parma 124
Santa Clara 99
Hong Kong 71
Beijing 56
Boardman 46
Munich 46
Shanghai 45
Los Angeles 44
Milan 43
Dearborn 42
Hefei 40
Johannesburg 37
New York 34
Chicago 25
Ho Chi Minh City 25
Modena 24
Nanjing 21
Princeton 21
Bologna 19
Redmond 17
Reggio Emilia 17
Bremen 16
São Paulo 15
Moscow 14
Vienna 14
Columbus 13
Hanoi 13
Helsinki 13
Brussels 12
Buffalo 12
Jakarta 12
Wayne 12
Abidjan 11
Amsterdam 10
Florence 10
Rome 10
Seoul 10
The Dalles 10
Warsaw 10
Wilmington 10
Frankfurt am Main 9
Izmir 9
Nuremberg 9
San Mateo 9
Shenyang 9
Turku 9
Council Bluffs 8
Des Moines 8
Jinan 8
Verona 8
Woodbridge 8
Bari 7
Binche 7
Denver 7
London 7
Nanchang 7
Seattle 7
Tokyo 7
Brasília 6
Chennai 6
Dong Ket 6
Follonica 6
Fremont 6
Houston 6
Leuven 6
Marseille 6
Stockholm 6
Tianjin 6
Belo Horizonte 5
Bengaluru 5
Hebei 5
Phoenix 5
Phủ Lý 5
Wuhan 5
Baghdad 4
Bitonto 4
Brescia 4
Campinas 4
Casalgrande 4
Da Nang 4
Düsseldorf 4
Guangzhou 4
Kunming 4
Mons 4
Neviano degli Arduini 4
Norwalk 4
Padova 4
Poplar 4
Rio de Janeiro 4
Salsomaggiore Terme 4
Soliera 4
Tashkent 4
Viamão 4
Alvignano 3
Totale 2.650
Salva come PNG Salva come JPEG
Nome #
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR 308
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines 218
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib 205
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC) 203
Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer 179
Dual inhibition of CDK4/6 and PI3K/AKT/mTOR signaling impairs energy metabolism in MPM cancer cells 177
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 169
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 163
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 162
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 146
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion 135
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN 135
CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells 133
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells (Frontiers in Oncology, (2022), 12, (942341), 10.3389/fonc.2022.942341) 131
INCREASED SOLUBLE AND MEMBRANE-BOUND PD-L1 EXPRESSION IN NSCLC CELL LINES TREATED WITH PEMETREXED 121
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells 116
Biological hallmarks and new therapeutic approaches for the treatment of pdac 115
Overcoming Palbociclib Resistance by Combined Treatment with PI3K/AKT/mTOR Inhibitors in Mesothelioma Cells 112
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines 111
PD-L1 OVEREXPRESSION INDUCES ANGIOGENIC CYTOKINE SECRETION AND ENDOTHELIAL CELL MIGRATION VIA STAT SIGNALLING. 110
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells 109
Circulating TGF-Beta and PD-L1 in Pancreatic Cancer 108
PD-L1 level is up-regulated in NSCLC cells after pemetrexed treatment 107
It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer 98
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells 91
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines 91
State of the art and perspectives in pediatric hepatocellular carcinoma 90
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 81
Correction to: Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer (Cancers, (2020), 12, 3, (666), 10.3390/cancers12030666) 63
PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition 62
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 59
Correction to: The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells (Journal of Experimental & Clinical Cancer Research, (2018), 37, 1, (72), 10.1186/s13046-018-0741-3) 35
Role of Cytokines and Other Soluble Factors in Tumor Development: Rationale for New Therapeutic Strategies 33
Totale 4.176
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.343
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 14 21 27 28 14 28 33
2021/2022176 22 13 24 8 3 3 28 4 11 8 8 44
2022/2023619 44 56 45 39 48 58 12 60 198 6 36 17
2023/2024390 14 23 21 14 48 56 33 25 12 32 55 57
2024/20251.050 38 40 60 70 101 110 114 69 107 92 102 147
2025/20261.273 182 213 349 218 296 15 0 0 0 0 0 0
Totale 4.176